Atlas Trials

To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)

Clinical trial NCT06264310 · COMPLETED

Trial details

NCT number
NCT06264310
Sponsor
River 2 Renal Corp.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Heart FailureWorsening Heart Failure (WHF)
Start date
2024-03-01
Primary completion
2024-11-04
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.